• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    12.70 Down 0.08(0.63%) Mar 27, 4:00PM EDT
    |After Hours : 12.70 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:12.78
    Open:12.71
    Bid:11.45 x 1000
    Ask:13.66 x 1000
    1y Target Est:24.25
    Beta:5.99
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:12.60 - 12.96
    52wk Range:10.85 - 18.48
    Volume:1,333,162
    Avg Vol (3m):1,735,770
    Market Cap:1.32B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 0.63%1.32B
    BAXUp 0.78%37.19B
    SHPGUp 1.04%47.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):122.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.94
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback